INSIGHTS ON CLINICAL TRIAL PARTNERING
-
How To Advance Self-Administered Therapies
Scale your biologic fill-finish from vials to autoinjectors without disruption. See how integrated device assembly capabilities support every clinical phase through commercialization.
-
Equitable Access To Clinical Trials & The Trial Modernization Act
How are the Equitable Access to Clinical Trials (EACT) initiative and Clinical Trial Modernization Act (CTMA) being used to improve clinical trial inclusivity by addressing financial barriers?
-
Killing Excel: The Quiet Crisis In Clinical Trials
Stop relying on spreadsheets for critical clinical trial decisions. Learn how standardizing vendor selection eliminates inefficiencies and protects budgets.
-
The Site-Sponsor Digital Divide Is Slowing Clinical Trial Innovation
Clinical trial site digitization often stalls due to operational, cultural, and structural barriers. Site-centered workflows can overcome these, boosting efficiency, visibility, and execution.
-
Two Views Of Risk When Choosing An IRT/RTSM Software Partner5/5/2026
In this clip, Ryan Keane of Korio explains why legacy RTSM vendors, designed for large pharmaceutical companies, often struggle to serve smaller, fast-moving Sponsors.
-
Prospecting Biospecimen Collections To Power Precision Medicine10/15/2025
High-quality biospecimens are the foundation of precision medicine success. Learn the five crucial steps—from planning to compliance—for a prospective biospecimen collection that is scientifically robust and accelerates your research.
-
Who Owns The Work Behind Clinical Trial Complexity?9/3/2026
Site burden often points to unclear ownership. This article examines how recurring administrative work reaches sites, where standardization helps, and when responsibility should shift.
-
When Vendor Disruption Threatens Trial Timelines: What Sponsors Should Do Next9/30/2026
When vendors face disruptions, trials can be affected. Discover key questions to assess partner stability, strengthen operational resilience, and keep studies on track.
-
What The Suvoda-Greenphire Merger Means For Clinical Trials2/18/2026
Simplify the clinical trial journey by unifying logistics, data, and payments. Reduce administrative friction for sites and improve the patient experience to accelerate trial timelines.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Did you know? Altasciences’ clinical facilities are integrated with state-of-the-art flow cytometry laboratories. With our deep expertise in regulated cellular analysis, our team ensures that every step — from sample collection and processing to transport and analysis — is optimized for precision and speed.
-
The Avacare team expertly supports site operational needs through a proven, turnkey research infrastructure, giving clinical staff the freedom to focus on patient care delivery.
-
Explore validated pain models and integrated early-phase services designed to characterize dose response, evaluate safety and efficacy, and support informed decisions in analgesic development.
-
With effective IVD regulatory consulting from an expert team, sponsors can transform challenges into competitive advantages and bring high-quality diagnostics to market more efficiently.
-
Accelerate study start-up with the right sites, patients, and partnerships
As protocols become more complex and sites face new pressures, your site selection strategy needs to be more nuanced than ever before. At Parexel, we bring that nuance and precision with the help of our Site Alliance Strategists, Community Alliance Network and Launch Excellence Office — a team who are committed to launching your projects quickly and efficiently with expertise in all key functions in clinical development strategy, planning, oversight, and delivery execution.